Eye90 Microspheres

· ABK Biomedical

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Eye90 Microspheres, covering 2024-11-29 to 2026-03-04. Get the full timeline:

Most recent: Clinical Trial Update: Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC) [NA]